Pattern of Dyslipidemia Among Patients With Acute Coronary Syndrome at Sohag University Hospital
NCT ID: NCT04951401
Last Updated: 2022-02-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
100 participants
OBSERVATIONAL
2021-08-01
2021-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Lipid Profile in Acute Coronary Syndrome
NCT05126043
Study of Lipid Profile of Patients With Chronic Coronary Syndromes at Sohag University Hospital
NCT04977089
Levels of Triglycerides and HDL-C in ACS Patients
NCT03429517
Early Results Of Coronary Artery Reconstruction For Extensive Coronary Disease
NCT05891392
Premature Coronary Artery Disease and Familial Dyslipidemia in Patients Presenting With Acute Coronary Syndrome
NCT07267312
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Acute Coronary Syndrome (ACS) is a major reason for Coronary Care Unit ( CCU )sohag university hospital admission The risk of CAD was about 4 and 3 times higher in male and female smokers than nonsmokers respectively (Baba S et. al ; 2006) Dyslipidemia has been identified as one of most important modifiable risk factor for CAD . Treating dyslipidemia has clear benefits in the primary and secondary prevention of coronary heart disease (CHD) in both sexes . This study focused on dyslipidemia as a risk factor of acute coronary syndrome (ACS).
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
OTHER
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Normal & abnormal lipid parameters value
parameters value among normal and abnormal lipid profile
lipid profile
lipid profile
ECG
ECG
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
lipid profile
lipid profile
ECG
ECG
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
\-
Exclusion Criteria
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Sohag University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Esraa Mostafa Abdelfattah
principal investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
esraa m abdelfatah, resident
Role: PRINCIPAL_INVESTIGATOR
esraa m abdelfatah
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Sohag University Hospital
Sohag, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Graichen C, Tanner C. Diagnosis of Acute Coronary Syndrome. Am Fam Physician. 2018 Aug 1;98(3):Online. No abstract available.
Dali B. Clinical Profile, Dyslipidemia and ACS - a Correlation. JNMA J Nepal Med Assoc. 2014 Jul-Sep;52(195):907-13.
Ray KK, Ditmarsch M, Kallend D, Niesor EJ, Suchankova G, Upmanyu R, Anzures-Cabrera J, Lehnert V, Pauly-Evers M, Holme I, Stasek J, van Hessen MW, Jones P; dal-ACUTE Investigators. The effect of cholesteryl ester transfer protein inhibition on lipids, lipoproteins, and markers of HDL function after an acute coronary syndrome: the dal-ACUTE randomized trial. Eur Heart J. 2014 Jul 14;35(27):1792-800. doi: 10.1093/eurheartj/ehu105. Epub 2014 Mar 17.
Eisen A, Giugliano RP, Braunwald E. Updates on Acute Coronary Syndrome: A Review. JAMA Cardiol. 2016 Sep 1;1(6):718-30. doi: 10.1001/jamacardio.2016.2049.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
soh-Med-21-06-06
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.